# A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

> **NCT02357069** · PHASE3 · UNKNOWN · sponsor: **LG Life Sciences** · enrollment: 372 (estimated)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Enbrel
- **DRUG:** LBEC0101

## Key facts

- **NCT ID:** NCT02357069
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 372 (ESTIMATED)
- **Last updated:** 2016-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02357069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02357069, "A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02357069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*